Five-Years Tigecycline Experience an Analysis of Real-Life Data
HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI, vol.56, no.2, pp.125-130, 2018 (ESCI, Scopus, TRDizin)
- Publication Type: Article / Article
- Volume: 56 Issue: 2
- Publication Date: 2018
- Doi Number: 10.4274/haseki.42713
- Journal Name: HASEKI TIP BULTENI-MEDICAL BULLETIN OF HASEKI
- Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
- Page Numbers: pp.125-130
- Keywords: Tigecycline, real life data, minocycline, EFFICACY, GLYCYLCYCLINE, GAR-936, TETRACYCLINE, INFECTIONS, BINDING, SAFETY, MODEL
- Recep Tayyip Erdoğan University Affiliated: No
Abstract
Aim: Tigecycline has been approved by the Food and Drug Administration for the treatment of complicated intra-abdominal infections, skin and soft tissue infections and community-acquired pneumonia. In our study, we examined the efficacy of tigecycline in clinical practice and reported real life data from our hospital over a period of five years.